MedTrace Logo

Evaluation of the Role of Epstein-Bar Virus in Patients With Pulmonary Arterial Hypertension

NCT06550648 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2024-08-13

No results posted yet for this study

Summary

Evaluate the role of Epstein-Barr virus infection in PAH (Idiopathic and connective tissue disease).

This by obtaining a blood sample from the PAH patients undergoing right heart cathetrization as well as obtaining the endothelial cells from the balloon tipped catheters and extracting the EBV virus to detect its presence.

IgG, IgM and PCR for EBV tests will be done.

Conditions

Interventions

PROCEDURE

Right Heart Catheterization (Swan Ganz Catheter)

Swan Ganz Catheter only for PAH patients, Using the swan ganz and pressure transducer

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Hoda MM Abdel-Hamid, MD · Assistant Professor

  • Jumana H Ismail, MD · Lecturer

  • Hala G Metwally, MD · Professor

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-03-30
Completion
2024-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06550648 on ClinicalTrials.gov